Takhzyro ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

takhzyro

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedem, dedno - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

Verkazia ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

verkazia

santen oy - ciklosporin - conjunctivitis; keratitis - oftalmologi - zdravljenje hude pomladnega keratoconjunctivitis (vkc) v otroke od 4 leta starosti in mladostnikih.

Fampridine Accord ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multiple skleroza - druga zdravila na živčnem sistemu - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Roclanda ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

roclanda

santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - oftalmologi - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.

Evkeeza ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

evkeeza

ultragenyx germany gmbh - evinacumab - hiperholesterolemija - sredstva za spreminjanje lipidov - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).